• LEARN MORE ABOUT KEYNOTE 695
  • About
    • About
    • Join The Team
    • Management Team
  • Pipeline
  • Technology
    • Technology
    • Tavo
    • VLA
    • Combination Approach
    • Publications
  • Partnering
  • Patients
    • Patients
    • Resources
    • Expanded Access
    • Together Against Cancer
  • Investors
  • Media
  • Contact
OncoSec Medical Incorporated
  • About
    • About
    • Join The Team
    • Management Team
  • Pipeline
  • Technology
    • Technology
    • Tavo
    • VLA
    • Combination Approach
    • Publications
  • Partnering
  • Patients
    • Patients
    • Resources
    • Expanded Access
    • Together Against Cancer
  • Investors
  • Media
  • Contact

Press Releases

Investors

Investors

  • Overview
    • Profile
    • Contacts
  • Events & Presentations
  • Analysts
  • Press Releases
    • Email Alerts
  • Financial Info
  • Stock Info
    • Quote
    • Charts
    • Historical Data
  • Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • FAQ
  • Press Releases

  • Email Alerts

OncoSec to Present at 15th Annual Biotech and Specialty Pharmaceuticals Conference

Nov 28, 2011 6:01am EST

OncoSec Appoints Scientific Advisory Board

Nov 21, 2011 6:01am EST

OncoSec and Serametrix Collaborate to Identify Potential Biomarkers to Enhance Skin Cancer Immune Therapies

Nov 16, 2011 6:01am EST

OncoSec to Present at Medical Device Investor Forum

Nov 14, 2011 6:01am EST

Device Master File for OncoSec Medical System Completed and Submitted to FDA

Oct 20, 2011 6:01am EDT

OncoSec Releases Devices for Use in Clinical Trials

Oct 05, 2011 6:01am EDT

OncoSec to Present at Cancer Immunotherapy Conference

Oct 04, 2011 6:01am EDT

Update: OncoSec Announces Positive Results From Head & Neck and Breast Cancer Trials

Sep 26, 2011 2:46pm EDT

OncoSec Announces Positive Results from Head & Neck and Breast Cancer Trials

Sep 26, 2011 6:01am EDT

OncoSec Medical to Attend 6th Annual Fire, Ice and Beyond: The Future of Ablation Therapies Conference

Sep 22, 2011 6:01am EDT
RSS
  • Prev
    • 1...
    • 33
    • 34
    • 35
    • 36
    • 37
    • 38
    • 39
    • 40
    • 41
    • 42
    Next
    • Email Alerts
    • Contacts
    • RSS News Feed
    logo

    Sign Up for our mailing list to stay current on all of our exciting new research and developments.

    Get Email Alerts
    OncoSec’s investigational products have not been approved or cleared by the FDA.

    Links

    • About
    • Pipeline
    • Technology
    • Partnering
    • Patients
    • Media
    • Investors
    • Contact
    • KEYNOTE 695 CLINICAL TRIAL

    Contact

    New Jersey Headquarters
    24 N. Main St
    Pennington, NJ 08534

    R&D Laboratories
    3565 General Atomics Court #100
    San Diego, CA 92121

    p | 855.662.6732
    f | 858.430.3832

    Investors@OncoSec.com


    © 2021 OncoSec Medical Incorporated. All Rights Reserved. Q12-003052-01 REV E.